First in Human: Who and what makes a cancer phase 1 trial and why are they so important?

Welisch, Gaston; Twelves, Chris; Plummer, Ruth; Evans, Jeff; Danson, Sarah; Syemonides, Stefan; Halsey, Chris; Rob, Jones; Hanna, Catherine; Gallagher, Peter; Walls, Gerard; Taylor, Kirsty; Barnett, Shelby; Forde, Caroline; White, Mark; Williams, Chris; El Badri, Salma; Bong'eni, David Chipole; Keith, Nicol

First in Human: Who and what makes a cancer phase 1 trial and why are they so important?

Output Details

Welisch, Gaston, Twelves, Chris, Plummer, Ruth, Evans, Jeff, Danson, Sarah, Syemonides, Stefan, Halsey, Chris, Rob, Jones, Hanna, Catherine, Gallagher, Peter, Walls, Gerard, Taylor, Kirsty, Barnett, Shelby, Forde, Caroline, White, Mark, Williams, Chris, El Badri, Salma, Bong'eni, David Chipole and Keith, Nicol (2021) First in Human: Who and what makes a cancer phase 1 trial and why are they so important? Project Report. Open Science Framework.
[Monograph]

Documents
Further Details
Staff Profiles

[A][B][+][-]

Documents

9487:60352

[A][B][+][-]

9487:60352

First in Human: Who and what makes a cancer phase 1 trial and why are they so important?

Published Version Download (3MB) CC BY 4.0

Further Details

Creators/Authors:

Welisch, Gaston, Twelves, Chris, Plummer, Ruth, Evans, Jeff, Danson, Sarah, Syemonides, Stefan, Halsey, Chris, Rob, Jones, Hanna, Catherine, Gallagher, Peter, Walls, Gerard, Taylor, Kirsty, Barnett, Shelby, Forde, Caroline, White, Mark, Williams, Chris, El Badri, Salma, Bong'eni, David Chipole and Keith, Nicol

Abstract:

Bringing new cancer therapies into routine cancer care is a long and complex process. Phase 1 clinical trials assess new cancer treatments in people for the first time. It is a critical step in the pathway. The aim of this project is to make the world of a cancer Phase 1 trialist and the value they bring, understandable to others. From those interested in careers in cancer clinical trials to stakeholders and partners seeking to innovate across the cancer control continuum, through a deeper understanding and insight of those involved.

Official URL:

https://doi.org/10.17605/OSF.IO/KWHQF

Additional Information:

Full Project resources are available from https://doi.org/10.17605/OSF.IO/KWHQF

Uncontrolled Keywords:

adaptation, barriers and fears, clinical trials, Covid and cancer, Covid testing, dataset, digital tools, ethics, global perspective, human impact, impact on research, industry, mortality, networking, opportunities, patient experience, patient recruitment, regulation, remote care, resilience, systemic impact, training

School/Academic Area:

Research

Dates:

Date

Date Type

9 June 2021

Published Online

Status:

Published

Identification Number:

10.17605/OSF.IO/KWHQF

Related URLs:

Copyright and Open Access Information:

Published under a CC-By Attribution 4.0 International licence: https://creativecommons.org/licenses/by/4.0/

Output Type:

Monograph (Project Report)

Output ID:

9487

Date Deposited:

07 Oct 2024 13:20

Last Modified:

07 Oct 2024 13:20

Deposited By:

Gaston Welisch

Staff Profiles

Gaston Welisch

Research Associate

View Profile

GSA Staff: request a change

RADAR Editors: update this record